Marianna B. Ruzinova

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 10 papers. Top paper: “DUSP6 mediates resistance to JAK2 inhibition and drives leukemic progression”.

DUSP6 mediates resistance to JAK2 inhibition and drives leukemic progression

bioRxiv (Cold Spring Harbor Laboratory)(2021)10.1101/2021.06.27.449656

N/A

0DataRank · unranked

14 citations

Angelo B. A. Laranjeira, Kangning Yang, Daniel A.C. Fisher, LaYow Yu, Anthony Z. Wang +8 more

IRAK4 Signaling Drives Resistance to Checkpoint Immunotherapy in Pancreatic Ductal Adenocarcinoma

Gastroenterology(2022)10.1053/j.gastro.2022.02.035

N/A

0DataRank · unranked

63 citations

Daoxiang Zhang, Paarth B. Dodhiawala, Varintra E. Lander, Xiuting Liu, Liang‐I Kang +8 more

DUSP6 mediates resistance to JAK2 inhibition and drives leukemic progression

Nature Cancer(2022)10.1038/s43018-022-00486-8

N/A

0DataRank · unranked

40 citations

Angelo B. A. Laranjeira, Kangning Yang, Daniel A.C. Fisher, LaYow Yu, Laure Poittevin De La Frégonnière +10 more

IMC-Denoise: a content aware denoising pipeline to enhance Imaging Mass Cytometry

Nature Communications(2023)10.1038/s41467-023-37123-6

N/A

0DataRank · unranked

61 citations

Karolyn A. Oetjen, Diane E. Bender, Marianna B. Ruzinova, Daniel A.C. Fisher, Kevin G. Shim +6 more

Chemokine Receptor 2 Targeted PET/CT Imaging Distant Metastases in Pancreatic Ductal Adenocarcinoma

ACS Pharmacology & Translational Science(2023)10.1021/acsptsci.3c00303

N/A

0DataRank · unranked

2 citations

Lisa Detering, Gyu Seong Heo, Deborah Sultan, Hannah Luehmann, Lin Li +13 more

Data from Constitutive IRAK4 Activation Underlies Poor Prognosis and Chemoresistance in Pancreatic Ductal Adenocarcinoma

(2023)10.1158/1078-0432.c.6525797

N/A

0DataRank · unranked

0 citations

Lin Li, Hongmei Jiang, Brett L. Knolhoff, A. Craig Lockhart, Andrea Wang‐Gillam +4 more

Combined KRAS-MAPK pathway inhibitors and HER2-directed drug conjugate is efficacious in pancreatic cancer

Nature Communications(2024)10.1038/s41467-024-46811-w

N/A

0DataRank · unranked

31 citations

Peng Liu, Kuljeet Seehra, Sapana Bansod, Yali Chen, Kiran Zahra +22 more

Post-Transplant Lymphoproliferative Disorders

Seminars in Nephrology(2024)10.1016/j.semnephrol.2024.151503

N/A

0DataRank · unranked

21 citations

Marianna B. Ruzinova, Lianna J. Marks, Vikas R. Dharnidharka

HMGA2 Expression Predicts Subtype, Survival, and Treatment Outcome in Pancreatic Ductal Adenocarcinoma

Clinical Cancer Research(2024)10.1158/1078-0432.ccr-24-2200

N/A

0DataRank · unranked

8 citations

Stephanie Dobersch, Ian M. Loveless, Annie N. Samraj, Gun Ho Jang, Miki Haraguchi +17 more

The Post-transplant Lymphoproliferative Disorders—Metagenomic Shotgun Microbial Sequencing (PTLD-MSMS) Study Methods and Protocol

Transplantation Direct(2024)10.1097/txd.0000000000001723

N/A

0DataRank · unranked

0 citations

Kristine M. Wylie, Todd Wylie, Marianna B. Ruzinova, Charles W. Goss, Gregory A. Storch +16 more